D.C. Diagnosis is STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.
It’s been a very rocky year for the Biotechnology Innovation Organization
When Michelle McMurry-Heath took over BIO, the sprawling organization representing some 1,000 drug companies in Washington, she vowed to transform the organization’s image in this town. That transformation threatened to tear the organization apart.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
